ConductScience.org, home

Paper6232086

Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureus.

Arbeit RD and 3 others. Diagn Microbiol Infect Dis, 1984. Cited by 146 papers, by iCite.

Cite this record

ConductScience Library. Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureus. Papers, record 6232086. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6232086

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureus.
PubMed
Journal
Diagn Microbiol Infect Dis
PubMed
Year
1984
PubMed
Publication types
Comparative Study, Journal Article, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
146
iCite
Relative citation ratio, by iCite
5
iCite
Revised in PubMed
2019-09-04
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Arbeit RDR D
2Karakawa WWW W
3Vann WFW F
4Robbins JBJ B

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Polysaccharides, BacterialMajor topic
Staphylococcus aureusMajor topic
Antigens, Bacterial
Humans
Sepsis
Serotyping
Staphylococcal Infections
Staphylococcus Phages

Source PubMed

Download CSV of topics

Cited by72

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 146 citations.

PMIDTitleJournalYearIn PapersSource
41170422Bacterial and host interactions in Staphylococcus aureus-induced septic arthritis-understanding pathogenesis and exploring therapeutic strategies.Front Microbiol2025https://conductscience.org/library/papers/41170422PubMed
35129409Investigational agents for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: progress in clinical trials.Expert Opin Investig Drugs2022https://conductscience.org/library/papers/35129409PubMed
31736914Comparative Genome Analysis of Staphylococcus lugdunensis Shows Clonal Complex-Dependent Diversity of the Putative Virulence Factor, ess/Type VII Locus.Front Microbiol2019https://conductscience.org/library/papers/31736914PubMed
31190912Recent advances in Staphylococcus aureus infection: focus on vaccine development.Infect Drug Resist2019https://conductscience.org/library/papers/31190912PubMed
29941424MsaB and CodY Interact To Regulate Staphylococcus aureus Capsule in a Nutrient-Dependent Manner.J Bacteriol2018https://conductscience.org/library/papers/29941424PubMed
28422567Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection.Hum Vaccin Immunother2017https://conductscience.org/library/papers/28422567PubMed
28239370capB2 Expression Is Associated with Staphylococcus aureus Pathogenicity.Front Microbiol2017https://conductscience.org/library/papers/28239370PubMed
27213458Entirely Carbohydrate-Based Vaccines: An Emerging Field for Specific and Selective Immune Responses.Vaccines (Basel)2016https://conductscience.org/library/papers/27213458PubMed
26781313MsaB activates capsule production at the transcription level in Staphylococcus aureus.Microbiology (Reading)2016https://conductscience.org/library/papers/26781313PubMed
25852165USA300 and USA500 clonal lineages of Staphylococcus aureus do not produce a capsular polysaccharide due to conserved mutations in the cap5 locus.mBio2015https://conductscience.org/library/papers/25852165PubMed
25245803Antibodies to Staphylococcus aureus serotype 8 capsular polysaccharide react with and protect against serotype 5 and 8 isolates.Infect Immun2014https://conductscience.org/library/papers/25245803PubMed
24998740Models matter: the search for an effective Staphylococcus aureus vaccine.Nat Rev Microbiol2014https://conductscience.org/library/papers/24998740PubMed
24753256The capsular polysaccharide of Staphylococcus aureus is attached to peptidoglycan by the LytR-CpsA-Psr (LCP) family of enzymes.J Biol Chem2014https://conductscience.org/library/papers/24753256PubMed
23658268Rapid and reliable identification of Staphylococcus aureus capsular serotypes by means of artificial neural network-assisted Fourier transform infrared spectroscopy.J Clin Microbiol2013https://conductscience.org/library/papers/23658268PubMed
22754017Comparison of Capsular Typing of Staphylococcus aureus with Bacteriophage Typing: A Study in Gulbarga, India.Indian J Microbiol2011https://conductscience.org/library/papers/22754017PubMed
21501445An evaluation of the emerging vaccines and immunotherapy against staphylococcal pneumonia in children.BMC Public Health2011https://conductscience.org/library/papers/21501445PubMed
20065327
Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.
Clin Microbiol Rev2010https://conductscience.org/library/papers/20065327PubMed
19185345Biomimetic strategies based on viruses and bacteria for the development of immune evasive biomaterials.Biomaterials2009https://conductscience.org/library/papers/19185345PubMed
18540063Expression, purification, crystallization and preliminary diffraction analysis of CapF, a capsular polysaccharide-synthesis enzyme from Staphylococcus aureus.Acta Crystallogr Sect F Struct Biol Cryst Commun2008https://conductscience.org/library/papers/18540063PubMed
17893153
Phase II, randomized, multicenter, double-blind, placebo-controlled trial of a polyclonal anti-Staphylococcus aureus capsular polysaccharide immune globulin in treatment of Staphylococcus aureus bacteremia.
Antimicrob Agents Chemother2007https://conductscience.org/library/papers/17893153PubMed

See all 72 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6232086

GET https://conductscience.org/api/papers/v1/6232086/cited_by?page=2